🔎 Trials Near Me

Akèy › Adenom selil ilot › Kalifòni

Etid klinik pou Adenom selil ilot nan Kalifòni

7 etid pou Adenom selil ilot ap chèche patisipan nan sit nan Kalifòni.

Vil nan Kalifòni

Tèks ofisyèl etid la (Anglè)

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  • Cedars-Sinai Medical Center, Beverly Hills
  • Norris Comprehensive Cancer Center, Los Angeles
  • Stanford Cancer Center, Palo Alto
  • ak 2 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06943755

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT05687123

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

  • Research Facility, Irvine
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT05477576

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

  • City of Hope, Duarte
  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
  • Stanford Cancer Institute, Stanford
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Mar 17, 2026 · NCT04119024

Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

  • University of California, Los Angeles, Los Angeles
  • Univeristy of California, San Diego, San Diego
  • University of California, San Francisco, San Francisco
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jan 26, 2026 · NCT05746182

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • PCR Oncology, Arroyo Grande
  • Tower Cancer Research Foundation, Beverly Hills
  • ak 25 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT05040360

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.